Trinity Biotech (TRIB) Institutional Ownership $1.16 +0.01 (+0.87%) Closing price 04:00 PM EasternExtended Trading$1.16 +0.01 (+0.43%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Trinity Biotech (NASDAQ:TRIB)CurrentInstitutional OwnershipPercentage78.97%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$6.25MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$268.90K Get TRIB Insider Trade Alerts Want to know when executives and insiders are buying or selling Trinity Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TRIB Institutional Buying and Selling by Quarter Trinity Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Perceptive Advisors LLC1,790,000$1.16M0.1%N/A9.917% 8/5/2025 Hunter Associates Investment Management LLC437,910$284K0.0%+16.7%2.426% 2/13/2025 Renaissance Technologies LLC189,053$166K0.0%-24.4%1.047% 1/23/2025 Hunter Associates Investment Management LLC378,590$334K0.1%+5.2%0.000% 10/24/2024 Hunter Associates Investment Management LLC359,810$390K0.1%+7.8%4.722% 8/6/2024 Acadian Asset Management LLC72,110$149K0.0%-38.0%0.946% 5/17/2024 Whitefort Capital Management LP81,902$167K0.1%-80.0%1.075% 5/10/2024 Acadian Asset Management LLC116,276$237K0.0%-83.0%1.526% 5/2/2024 Hunter Associates Investment Management LLC317,810$644K0.1%-80.5%4.171% 1/31/2024 Hunter Associates Investment Management LLC1,625,900$700K0.1%-6.1%4.266% Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/15/2023 Stonehill Capital Management LLC1,512,975$1.44M0.9%-4.7%3.970% 8/7/2023 Acadian Asset Management LLC727,954$701K0.0%-2.0%1.910% 8/3/2023 Hunter Associates Investment Management LLC1,724,000$1.66M0.3%-2.9%4.524% 7/13/2023 Cambridge Investment Research Advisors Inc.111,400$106K0.0%N/A0.292% 5/12/2023 Aristides Capital LLC162,317$153K0.1%-26.1%0.426% 5/2/2023 Hunter Associates Investment Management LLC1,775,100$1.68M0.4%-2.7%4.658% 2/1/2023 Hunter Associates Investment Management LLC1,823,633$1.81M0.4%+1.5%4.785% 11/2/2022 Hunter Associates Investment Management LLC1,797,190$1.91M0.5%-0.6%4.716% 8/10/2022 Hunter Associates Investment Management LLC1,808,533$2.20M0.5%-25.0%6.719% 5/12/2022 Acadian Asset Management LLC815,461$862K0.0%-3.3%3.901% 5/11/2022 Highbridge Capital Management LLC1,151,610$1.22M0.0%N/A5.510% 4/26/2022 Hunter Associates Investment Management LLC2,412,116$2.56M0.8%+5.5%11.540% 2/14/2022 Stonehill Capital Management LLC219,946$315K0.1%-55.0%1.052% 2/14/2022 Whitefort Capital Management LP35,068$50K0.0%N/A0.168% 2/10/2022 Acadian Asset Management LLC843,523$1.20M0.0%-1.4%4.036% 2/4/2022 Envestnet Asset Management Inc.110,901$159K0.0%N/A0.531% 1/27/2022 Hunter Associates Investment Management LLC2,286,150$3.27M0.9%+9.1%10.937% 11/18/2021Wealthsource Partners LLC30,200$65K0.0%N/A0.144% 11/15/2021 Marshall Wace LLP34,703$75K0.0%-37.5%0.166% 11/15/2021 Hunter Associates Investment Management LLC2,095,900$4.53M1.5%+2.0%10.027% 11/12/2021 Renaissance Technologies LLC1,746,841$3.77M0.0%-5.6%8.357% 10/28/2021 Navellier & Associates Inc.15,485$33K0.0%-84.6%0.074% 8/25/2021 Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/16/2021 Marshall Wace LLP55,557$163K0.0%-38.7%0.266% 8/13/2021 Renaissance Technologies LLC1,850,082$5.44M0.0%+0.3%8.851% 8/13/2021 LPL Financial LLC60,073$177K0.0%+171.5%0.287% 8/9/2021 Navellier & Associates Inc100,611$296K0.0%+23.1%0.481% (Data available from 1/1/2016 forward) TRIB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRIB shares? During the previous two years, the following institutional investors and hedge funds held shares of Trinity Biotech shares: Perceptive Advisors LLC ($1.16M), Hunter Associates Investment Management LLC ($284K), Whitefort Capital Management LP ($167K), and Renaissance Technologies LLC ($166K), Acadian Asset Management LLC ($149K).Learn more on Trinity Biotech's institutional investors. What percentage of Trinity Biotech's stock is owned by institutional investors? 78.97% of Trinity Biotech's stock is owned by institutional investors. Learn more on TRIB's institutional investor holdings. Which institutional investors have been buying Trinity Biotech's stock? The following institutional investors have purchased Trinity Biotech's stock in the last 24 months: Perceptive Advisors LLC ($1.79M), and Hunter Associates Investment Management LLC ($107.68K). How much institutional buying is happening at Trinity Biotech? Institutional investors have bought a total of 1,897,680 shares in the last 24 months. This purchase volume represents approximately $6.25M in transactions. Which of Trinity Biotech's major shareholders have been selling company stock? The following institutional investors have sold Trinity Biotech stock in the last 24 months: Renaissance Technologies LLC ($61.10K). How much institutional selling is happening at Trinity Biotech? Institutional investors have sold a total of 61,100 shares in the last 24 months. This volume of shares sold represents approximately $268.90K in transactions. Related Companies Galapagos Institutional Ownership Indivior Institutional Ownership InterCure Institutional Ownership Minerva Neurosciences Institutional Ownership Neonc Technologies Institutional Ownership This page (NASDAQ:TRIB) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
